Safety and Efficacy of YB-1113 in Treatment of POI

NCT05494723 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
6
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bright Cell, Inc.